Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−1.220EUR
−32.56 MEUR
712.00 KEUR
16.66 M
About SEQUANA MEDICAL
Sector
Industry
CEO
Ian Crosbie
Website
Headquarters
Ghent
Founded
2018
ISIN
BE0974340722
FIGI
BBG00MHD15H3
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company focuses on the treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. It offers alfapump, an implantable, programmable, wirelessly-charged, battery-powered system that manages refractory ascites and malignant ascites. The company was founded by Noel L. Johnson in 2006 and is headquartered in Ghent, Belgium.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SEQUA is 1.400 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange SEQUANA MEDICAL stocks are traded under the ticker SEQUA.
SEQUANA MEDICAL is going to release the next earnings report on Sep 5, 2024. Keep track of upcoming events with our Earnings Calendar.
SEQUA stock is 4.35% volatile and has beta coefficient of −0.36. Check out the list of the most volatile stocks — is SEQUANA MEDICAL there?
Yes, you can track SEQUANA MEDICAL financials in yearly and quarterly reports right on TradingView.
SEQUA stock has fallen by 3.45% compared to the previous week, the month change is a 19.54% fall, over the last year SEQUANA MEDICAL has showed a 60.23% decrease.
SEQUA net income for the last quarter is −16.10 M EUR, while the quarter before that showed −16.46 M EUR of net income which accounts for 2.21% change. Track more SEQUANA MEDICAL financial stats to get the full picture.
Today SEQUANA MEDICAL has the market capitalization of 42.34 M, it has increased by 1.06% over the last week.
No, SEQUA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SEQUA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SEQUANA MEDICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SEQUANA MEDICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SEQUANA MEDICAL stock shows the strong sell signal. See more of SEQUANA MEDICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SEQUANA MEDICAL future price: according to them, SEQUA price has a max estimate of 9.00 EUR and a min estimate of 2.90 EUR. Read a more detailed SEQUANA MEDICAL forecast: see what analysts think of SEQUANA MEDICAL and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SEQUANA MEDICAL EBITDA is −28.47 M EUR, and current EBITDA margin is −4.05 K%. See more stats in SEQUANA MEDICAL financial statements.